Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Yoshida

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter ConsortiumXiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Translational Vision Science & Technology|February 6, 2025
Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT ImagingKenta Yoshida, Neha Anegondi, Adam Pely, et al.
Clinical and Translational Science|April 14, 2022
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugsTatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, et al.
Clinical Pharmacology and Therapeutics|March 16, 2022
Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug InteractionsTatsuki Mochizuki, Maciej J Zamek-Gliszczynski, Kenta Yoshida, et al.
Clinical and Translational Science|September 28, 2021
Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trialSharon M Rymut, Siddharth Sukumaran, Gizette Sperinde, et al.
Clinical Pharmacology and Therapeutics|November 5, 2024
Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy VolunteersTomoki Koishikawa, Kaku Fujiwara, Kunal Taskar, et al.
World Journal of Surgical Oncology|July 19, 2017
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)Tomoko Hirakawa, Takeo Minaguchi, Yoshio Itani, et al.
Nature Reviews. Drug Discovery|January 24, 2024
Membrane transporters in drug development and as determinants of precision medicineAleksandra Galetin, Kim L R Brouwer, Donald Tweedie, et al.
Allergy|September 9, 2024
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthmaHorace Rhee, Lindsay M Henderson, Rebecca N Bauer, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter ConsortiumXiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Translational Vision Science & Technology|February 6, 2025
Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT ImagingKenta Yoshida, Neha Anegondi, Adam Pely, et al.
Clinical and Translational Science|April 14, 2022
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugsTatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, et al.
Clinical Pharmacology and Therapeutics|March 16, 2022
Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug InteractionsTatsuki Mochizuki, Maciej J Zamek-Gliszczynski, Kenta Yoshida, et al.
Clinical and Translational Science|September 28, 2021
Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trialSharon M Rymut, Siddharth Sukumaran, Gizette Sperinde, et al.
Clinical Pharmacology and Therapeutics|November 5, 2024
Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy VolunteersTomoki Koishikawa, Kaku Fujiwara, Kunal Taskar, et al.
World Journal of Surgical Oncology|July 19, 2017
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)Tomoko Hirakawa, Takeo Minaguchi, Yoshio Itani, et al.
Nature Reviews. Drug Discovery|January 24, 2024
Membrane transporters in drug development and as determinants of precision medicineAleksandra Galetin, Kim L R Brouwer, Donald Tweedie, et al.
Allergy|September 9, 2024
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthmaHorace Rhee, Lindsay M Henderson, Rebecca N Bauer, et al.
Pageof 16